EU's UPC grants Abbott preliminary injunction against Sibionics’ glucose monitor
Abbott Diabetes Care Inc. secured a preliminary injunction from the UPC Court of Appeal, blocking Sibionics from selling its GS1 continuous glucose monitor in multiple European countries. The appellate court overturned...To view the full article, register now.
Already a subscriber? Click here to view full article